* Medical researcher at Methodology Research Unit and Neonatologist at National Institute of Pediatrics in Mexico City; * Medical professor of Autonomous Metropolitan University; * Methodology professor of Universidad Nacional Autónoma de México; * Tutor of the program of master\'s and PhD in medical sciences.
Respiratory distress syndrome (RDS) is a disorder caused by a deficiency of surface-active agent called pulmonary surfactant, in the pulmonary alveoli. This deficiency leads the alveoli to collapse, impeding air entry, gas exchange, and oxygenation in newborns. Conventional treatment involves exogenous surfactant administration, ventilation, and hydroelectrolytic management.
Part of the book: Respiratory Management of Newborns